Table 4.
Quantitative assessment of the quality of nucleus segmentation, in each of the 10 cancer types.
Cancer Type | #. patch labels | Dice | Instance-Dice | Nuclei count | |
---|---|---|---|---|---|
Correlat. | MAE% | ||||
BLCA | 95 | 0.779 | 0.668 | 0.941 | 20.5% |
BRCA | 89 | 0.798 | 0.649 | 0.922 | 19.6% |
CESC | 79 | 0.818 | 0.677 | 0.947 | 13.4% |
GBM | 86 | 0.809 | 0.723 | 0.938 | 14.4% |
LUAD | 88 | 0.772 | 0.641 | 0.896 | 17.4% |
LUSC | 97 | 0.789 | 0.665 | 0.924 | 16.1% |
PAAD | 91 | 0.785 | 0.679 | 0.933 | 15.8% |
PRAD | 96 | 0.799 | 0.670 | 0.940 | 14.7% |
SKCM | 86 | 0.774 | 0.675 | 0.933 | 17.1% |
UCEC | 61 | 0.778 | 0.629 | 0.900 | 14.6% |
The p-value of Pearson correlation for every cancer type is smaller than 7.0 × 10−23.